The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
OASIS Diagnostics S.A.
+ business areaDiagnostics
2019 – 20,900 PLN
2020 – 19,300 PLN
2021 – 12,000 PLN
2022 – 17,500 PLN
2023 – 308,300 PLN
2024 – 1,100,000 PLN
2024 – 3
2019 - 6500 PLN
2020 - 934 PLN
2021 - 8500 PLN
2022 - 0 PLN
2023 - 490600 PLN
2024 - 2000000 PLN
OASIS Diagnostics S.A. is a Warsaw-based medical technology company focused on improving maternity care through the development and implementation of innovative, clinically validated diagnostic devices. Their solutions address gaps in obstetric standards and aim to enhance women’s quality of life after childbirth.
The company’s flagship project involves detecting obstetric anal sphincter injuries (OASIS) using impedance spectroscopy with the ONIRY Probe. This work is supported by EU funding under the *StartVenture\@Poland 2* program and the *POIR 1.1.1* competition. OASIS Diagnostics operates under ISO, CE, and MD certifications, combining a multidisciplinary healthcare-experienced team to advance preventive and diagnostic tools in women’s health.